Pivoting to virtual.

At the Swiss Venture Forum held in Lausanne on May 23rd, 2012, QGel was selected as a semi-finalist for the European Venture Summit in Berlin in December 2012. A special thanks to our pharmaceutical industry customers and congratulations to the QGel team who continue to produce overwhelming evidence for better drug development using QGel products for 3D cell based assays.

Categories:

Comments are closed